Novartis International AG

Photos: Novartis 12th Annual International BioCamp

Photos of attendees and winners of Novartis BioCamp
Multimedia with summary

Today, Novartis announced the winners of its twelfth annual International Biotechnology Leadership Camp (BioCamp), a three-day seminar bringing biotechnology and business experts together with 70 selected students from leading international universities in 24 countries and territories, originating from 31 different nations.

Novartis Announces Winners of its 12th Annual International Biotechnology Leadership Camp (BioCamp)

Novartis BioCamp engages students around scientific advances and entrepreneurial opportunities
Summary: 

Novartis International BioCamp highlights how collaboration and diversity drive innovation and inspires future science leaders

  • The International Biotechnology Leadership Camp (BioCamp) engages students around scientific advances and entrepreneurial opportunities
  • The interactive program brought 70 university students from 24 countries and territories to Novartis headquarters in Basel, Switzerland
    • Elena Gross, Sarmishtha Sharma and Masatoshi Takara are the winners of the case study competition
  • Novartis cultivates an inclusive high-performance environment encouraging collaboration by championing high performing teams with diversity and inclusion
Press Release

Novartis International BioCamp highlights how collaboration and diversity drive innovation and inspires future science leaders

  • The International Biotechnology Leadership Camp (BioCamp) engages students around scientific advances and entrepreneurial opportunities
  • The interactive program brought 70 university students from 24 countries and territories to Novartis headquarters in Basel, Switzerland
    • Elena Gross, Sarmishtha Sharma and Masatoshi Takara are the winners of the case study competition
  • Novartis cultivates an inclusive high-performance environment encouraging collaboration by championing high performing teams with diversity and inclusion

Novartis Celebrates 19th Annual Community Partnership Day With More Than 27,000 Associates Volunteering in Their Local Communities

Summary: 
  • More than 27,000 Novartis associates worldwide dedicate an estimated 200,000 hours to volunteer with charitable causes in their communities
  • Community Partnership Day symbolizes the company’s commitment to improving health and serving its local communities
  • Associates are participating in six continents and 63 countries in activities ranging from volunteering at hospitals, assisted living facilities, and schools to participating in blood donation campaigns and health screening activities
Press Release
  • More than 27,000 Novartis associates worldwide dedicate an estimated 200,000 hours to volunteer with charitable causes in their communities
  • Community Partnership Day symbolizes the company’s commitment to improving health and serving its local communities
  • Associates are participating in six continents and 63 countries in activities ranging from volunteering at hospitals, assisted living facilities, and schools to participating in blood donation campaigns and health screening activities

ReportAlert.info - Novartis (VTC:NOVZn) Publishes 2013 Corporate Responsibility Performance Report

The report enhances the company's transparency in several key areas, including in human resources, supply chain and ethics, and aims to meet the needs and expectations of CR professionals by offering easy access to key data
Press Release

July 9, 2014 /3BL Media/ - Novartis has published a Corporate Responsibility (CR) Performance Report for 2013. The report uses the new Global Reporting Initiative G4 guidelines, one year ahead of required implementation.

The Performance Report enhances the company’s transparency in several key areas, including in human resources, supply chain and ethics, and aims to meet the needs and expectations of CR professionals by offering easy access to key data. The report also details progress against Novartis priorities, defined following a CR materiality analysis completed in 2013.

Subscribe to Novartis International AG